Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06581471 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The TRICURE EU Pivotal Study

Study acronym: TRICURE EU
StatusRecruiting
PhaseNot applicable
SponsorTRiCares
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 30, 2025 to Oct 30, 2026v6
  2. Site details revised at 3 of 8 sitesv5
  3. Study sites: 1 to 8v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 31, 2024 to Aug 29, 2024
    • Site details revised
    v3
  5. Re-verified, no change to tracked fieldsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
TRiCares
4 trials monitored
See all monitored trials
Heart Disease
8,786 trials monitored
See 412 trials at risk
Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System
Trial Details
NCT Number NCT06581471
Lead Sponsor TRiCares
Conditions
(from sponsor)		 Tricuspid Valve Regurgitation, Heart Valve Disease, Cardiovascular Diseases
Related terms Cardiovascular Diseases, Heart Valve Diseases, Tricuspid Valve Insufficiency
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov